Shares of Health Care sector company argenx SE moved -2.1% today, and are now trading at a price of $435.92. The large-cap stock's daily volume was 412,241 compared to its average volume of 238,031. The S&P 500 index returned a -0.0% performance.
argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany, France, Canada, the United Kingdom, and Italy. The company is based in Amsterdam and has 843 full time employees. Its market capitalization is $28,727,478,272.
21 analysts are following argenx SE and have set target prices ranging from $490.0 to $615.0 per share. On average, they have given the company a rating of buy. At today's prices, ARGX is trading -23.43% away from its average analyst target price of $569.33 per share.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) |
|---|---|---|---|
| 2023 | -261,894 | nan | -261,894 |
| 2022 | -590,356 | nan | -590,356 |
| 2021 | -395,272 | nan | -395,272 |
| 2020 | 156,645 | nan | 156,645 |
| 2019 | 156,645 | nan | 156,645 |
| 2018 | -53,274 | nan | -53,274 |
